Fund moves

Hims & Hers Health (HIMS): Bridgewater Associates reduced its stake -149K shares

Bridgewater Associates reduced its stake in Hims & Hers Health, per its Q2 2025 13F.

598K
Shares reported · -149K vs prior quarter
0.12%
Disclosed portfolio weight
$29.8M
Reported value
Holdings as of
Jun 30, 2025
Filed
Aug 13, 2025

What stands out in this filing

  • 746,925 shares in Q1 2025, 598,029 now (−19.9% in share count).
  • Reported at $29.8M, 0.12% of the portfolio value in this 13F filing.
  • 6 other tracked managers reported the same kind of change for Q2 2025.

Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Jun 10, 2025InsiderOfficer sold ~$308K of HIMS shares in the open market
  2. Jun 16, 2025Insider · 2 peopleInsiders: 7 sales (~$10.3M)
  3. Jun 17, 2025Insider · 4 peopleInsiders: 5 sales (~$5.5M)
  4. Jun 23, 2025InsiderCFO sold ~$1.09M of HIMS shares in the open market
  5. Jun 30, 2025InsiderOfficer sold ~$130K of HIMS shares in the open market
  6. Jul 7, 2025InsiderCFO sold ~$540K of HIMS shares in the open market
  7. Jul 14, 2025Insider · 2 peopleInsiders: 2 sales (~$675K)
  8. Jul 16, 2025Insider · 1 personInsiders: 3 sales (~$2.5M)
  9. Jul 21, 2025Insider · 1 personInsiders: 4 sales (~$6.2M)
  10. Jul 23, 2025InsiderOfficer sold ~$770K of HIMS shares in the open market
  11. Jul 24, 2025InsiderOfficer sold ~$121K of HIMS shares in the open market
  12. Jul 28, 2025InsiderOfficer sold ~$151K of HIMS shares in the open market
  13. Jul 31, 2025InsiderOfficer sold ~$1.77M of HIMS shares in the open market
  14. Aug 1, 2025InsiderOfficer sold ~$16K of HIMS shares in the open market
  15. Aug 4, 2025CongressDisclosed purchase of HIMS — reported range $1,001 - $15,000
  16. Aug 6, 2025InsiderDirector sold ~$3.21M of HIMS shares in the open market
  17. Aug 7, 2025InsiderCEO sold ~$33.4M of HIMS shares in the open market
  18. Aug 11, 2025InsiderOfficer sold ~$133K of HIMS shares in the open market
  19. Aug 13, 2025InsiderCFO sold ~$556K of HIMS shares in the open market

What came next

  1. Aug 18, 2025Insider · 1 personInsiders: 6 sales (~$7.9M)
  2. Aug 25, 2025InsiderOfficer sold ~$114K of HIMS shares in the open market
  3. Aug 26, 2025InsiderCFO sold ~$506K of HIMS shares in the open market
  4. Sep 1, 2025Company filing · Form 8-K · Material agreementSigned an important agreement
  5. Sep 15, 2025Insider · 2 peopleInsiders: 3 sales (~$8.3M)
  6. Sep 16, 2025Insider · 1 personInsiders: 9 sales (~$9.4M)
  7. Sep 17, 2025Insider · 5 peopleInsiders: 5 sales (~$5.1M)
  8. Sep 22, 2025InsiderCFO sold ~$1.36M of HIMS shares in the open market
  9. Sep 24, 2025InsiderOfficer sold ~$119K of HIMS shares in the open market
  10. Sep 28, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“On September 28, 2025, Nader Kabbani, the Chief Operating Officer of Hims & Hers Health, Inc. (the “Company”) determined to step into a new advisory role for the Company effective November 2, 2025 (the “Transition Date”), where he will continue to provide ongoing strategic guidance to the Company and support for special global initiatives through July 2026.”
  11. Sep 29, 2025Insider · 2 peopleInsiders: 2 sales (~$5.3M)
  12. Oct 3, 2025InsiderCFO sold ~$669K of HIMS shares in the open market
  13. Oct 10, 2025InsiderOfficer sold ~$52K of HIMS shares in the open market
  14. Oct 13, 2025InsiderOfficer sold ~$143K of HIMS shares in the open market
  15. Oct 16, 2025Insider · 1 personInsiders: 9 sales (~$11.0M)
  16. Oct 17, 2025InsiderCFO sold ~$662K of HIMS shares in the open market
  17. Oct 27, 2025InsiderOfficer sold ~$132K of HIMS shares in the open market
  18. Nov 3, 2025Company filing · Form 8-K · ResultsReported its results
  19. Nov 10, 2025InsiderOfficer sold ~$112K of HIMS shares in the open market
  20. Nov 17, 2025InsiderCFO sold ~$853K of HIMS shares in the open market
View the official recordSEC Form 13F-HR

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for Hims & Hers Health

For Hims & Hers Health, OQRO holds 18 insider filings (SEC Form 4 or Form 144) and 2 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its HIMS page.

How this filing works

Explore the data

Common questions

What does this filing report about Hims & Hers Health (HIMS) stock?

Bridgewater Associates reduced its stake in Hims & Hers Health, per its Q2 2025 13F. Now 598K shares, $29.8M reported value, 0.12% of disclosed portfolio.

When did it happen, and when was it made public?

Holdings as of: Jun 30, 2025. Filed: Aug 13, 2025.

What stands out in this filing?

746,925 shares in Q1 2025, 598,029 now (−19.9% in share count). Reported at $29.8M, 0.12% of the portfolio value in this 13F filing. 6 other tracked managers reported the same kind of change for Q2 2025.

Is this a trade made on a known date?

No. A holdings report is a picture of the portfolio on the last day of the quarter. It shows what was held on that day, not the day or the price at which anything was bought or sold.

Where does this information come from?

From the SEC Form 13F-HR, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Hims & Hers Health recently?

For Hims & Hers Health, OQRO holds 18 insider filings (SEC Form 4 or Form 144) and 2 fund holdings reports (13F) dated in the last 90 days. They are listed on the HIMS page.

Does this mean HIMS stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Hims & Hers Health

Everything OQRO holds on this company is on its HIMS page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data